Saccharin — the sweetener in the pink packets — has one of the strangest histories in food science, from an accidental discovery to a near-ban and back. It's also a window into how food-safety law grapples with uncertainty.
An accidental discovery
In 1879, a chemist named Constantin Fahlberg, working in a laboratory studying coal-tar derivatives, noticed his dinner roll tasted unusually sweet. He traced it to a compound on his hands from the lab and had, essentially by accident, discovered saccharin — hundreds of times sweeter than sugar with no calories. It was the first artificial sweetener.
From wartime staple to household name
Saccharin found use as a sugar substitute, especially during sugar shortages in both World Wars, and later became popular with dieters and people managing diabetes. For decades it was the artificial sweetener.
The cancer scare
In the 1970s, studies found that very high doses of saccharin caused bladder tumors in rats. Under the strict Delaney Clause, which banned any additive shown to cause cancer, the FDA moved to ban it in 1977. Public backlash was fierce — saccharin was then the only artificial sweetener widely available — and Congress intervened, imposing a warning label instead of a ban while research continued.
Exonerated
Further research revealed that the rat tumors resulted from a mechanism specific to rats' urine chemistry that did not apply to humans. Saccharin was removed from the U.S. list of potential carcinogens, and in 2000 the warning label was dropped entirely. Saccharin is now considered safe by the FDA.
Why the story matters
Saccharin's saga became the classic example of the tension between the Delaney Clause's zero-tolerance rule and real-world risk assessment — a case that helped drive the shift toward weighing actual human risk. It's also a reminder that the science behind sweeteners and additives evolves, sometimes reversing earlier conclusions.